A Win For AN2 Therapeutics Inc.
Tue, May 16, 2023 at 07:42 PM
AN2 Therapeutics Inc. (ANTX:NASDAQ) jumped higher at $7.41, a gain of 36%. On Tue, May 16, 2023, ANTX:NASDAQ touched a New 2-Week High of $7.41. The stock appeared on our News Catalysts scanner on Thu, May 11, 2023 at 07:24 PM in the 'EARNINGS' category. From Tue, May 02, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
About AN2 Therapeutics Inc. (ANTX:NASDAQ)
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.
Top 10 Gainers:
- Exela Technologies, Inc. (XELA:NASDAQ), 103.9%
- Missfresh Limited (MF:NASDAQ), 50.29%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 45.85%
- The Singing Machine Company Inc. (MICS:NASDAQ), 41.9%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 40.69%
- SRAX, Inc. (SRAX:NASDAQ), 36.54%
- AN2 Therapeutics Inc. (ANTX:NASDAQ), 35.96%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 33.33%
- VivoPower International PLC (VVPR:NASDAQ), 30.76%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 29.58%